Copyright Reports & Markets. All rights reserved.

Global Antithyroid Medications for Hyperthyroidism Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Methimazole
    • 1.3.3 Propylthiouracil
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Antithyroid Medications for Hyperthyroidism Market Size & Forecast
    • 1.5.1 Global Antithyroid Medications for Hyperthyroidism Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Antithyroid Medications for Hyperthyroidism Sales Quantity (2021-2032)
    • 1.5.3 Global Antithyroid Medications for Hyperthyroidism Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.1.4 Merck Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Herbrand PharmaChemicals
    • 2.2.1 Herbrand PharmaChemicals Details
    • 2.2.2 Herbrand PharmaChemicals Major Business
    • 2.2.3 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.2.4 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Herbrand PharmaChemicals Recent Developments/Updates
  • 2.3 Future Health Pharma
    • 2.3.1 Future Health Pharma Details
    • 2.3.2 Future Health Pharma Major Business
    • 2.3.3 Future Health Pharma Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.3.4 Future Health Pharma Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Future Health Pharma Recent Developments/Updates
  • 2.4 Shanghai Zhaohui Pharmaceutical
    • 2.4.1 Shanghai Zhaohui Pharmaceutical Details
    • 2.4.2 Shanghai Zhaohui Pharmaceutical Major Business
    • 2.4.3 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.4.4 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
  • 2.5 Beijing Yanjing Pharmaceutical
    • 2.5.1 Beijing Yanjing Pharmaceutical Details
    • 2.5.2 Beijing Yanjing Pharmaceutical Major Business
    • 2.5.3 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.5.4 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
  • 2.6 Jinghua Pharmaceutical Group
    • 2.6.1 Jinghua Pharmaceutical Group Details
    • 2.6.2 Jinghua Pharmaceutical Group Major Business
    • 2.6.3 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.6.4 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Jinghua Pharmaceutical Group Recent Developments/Updates
  • 2.7 Guangzhou Kanghe Pharmaceutical
    • 2.7.1 Guangzhou Kanghe Pharmaceutical Details
    • 2.7.2 Guangzhou Kanghe Pharmaceutical Major Business
    • 2.7.3 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.7.4 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
  • 2.8 Zigong Honghe Pharmaceutical
    • 2.8.1 Zigong Honghe Pharmaceutical Details
    • 2.8.2 Zigong Honghe Pharmaceutical Major Business
    • 2.8.3 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.8.4 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
  • 2.9 Guangdong Huanan Pharmaceutical
    • 2.9.1 Guangdong Huanan Pharmaceutical Details
    • 2.9.2 Guangdong Huanan Pharmaceutical Major Business
    • 2.9.3 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.9.4 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
  • 2.10 Zibo Wankang Pharmaceutical Chemical
    • 2.10.1 Zibo Wankang Pharmaceutical Chemical Details
    • 2.10.2 Zibo Wankang Pharmaceutical Chemical Major Business
    • 2.10.3 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.10.4 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
  • 2.11 Qilu Pharmaceutical
    • 2.11.1 Qilu Pharmaceutical Details
    • 2.11.2 Qilu Pharmaceutical Major Business
    • 2.11.3 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Product and Services
    • 2.11.4 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Qilu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Antithyroid Medications for Hyperthyroidism by Manufacturer

  • 3.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Antithyroid Medications for Hyperthyroidism Revenue by Manufacturer (2021-2026)
  • 3.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Antithyroid Medications for Hyperthyroidism by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Antithyroid Medications for Hyperthyroidism Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Antithyroid Medications for Hyperthyroidism Manufacturer Market Share in 2025
  • 3.5 Antithyroid Medications for Hyperthyroidism Market: Overall Company Footprint Analysis
    • 3.5.1 Antithyroid Medications for Hyperthyroidism Market: Region Footprint
    • 3.5.2 Antithyroid Medications for Hyperthyroidism Market: Company Product Type Footprint
    • 3.5.3 Antithyroid Medications for Hyperthyroidism Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Antithyroid Medications for Hyperthyroidism Market Size by Region
    • 4.1.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2021-2032)
    • 4.1.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Region (2021-2032)
  • 4.2 North America Antithyroid Medications for Hyperthyroidism Consumption Value (2021-2032)
  • 4.3 Europe Antithyroid Medications for Hyperthyroidism Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value (2021-2032)
  • 4.5 South America Antithyroid Medications for Hyperthyroidism Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Antithyroid Medications for Hyperthyroidism Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2021-2032)
  • 5.2 Global Antithyroid Medications for Hyperthyroidism Consumption Value by Type (2021-2032)
  • 5.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2021-2032)
  • 6.2 Global Antithyroid Medications for Hyperthyroidism Consumption Value by Application (2021-2032)
  • 6.3 Global Antithyroid Medications for Hyperthyroidism Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2021-2032)
  • 7.2 North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2021-2032)
  • 7.3 North America Antithyroid Medications for Hyperthyroidism Market Size by Country
    • 7.3.1 North America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2021-2032)
  • 8.2 Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2021-2032)
  • 8.3 Europe Antithyroid Medications for Hyperthyroidism Market Size by Country
    • 8.3.1 Europe Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Antithyroid Medications for Hyperthyroidism Market Size by Region
    • 9.3.1 Asia-Pacific Antithyroid Medications for Hyperthyroidism Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Antithyroid Medications for Hyperthyroidism Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2021-2032)
  • 10.2 South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2021-2032)
  • 10.3 South America Antithyroid Medications for Hyperthyroidism Market Size by Country
    • 10.3.1 South America Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Antithyroid Medications for Hyperthyroidism Market Size by Country
    • 11.3.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Antithyroid Medications for Hyperthyroidism Market Drivers
  • 12.2 Antithyroid Medications for Hyperthyroidism Market Restraints
  • 12.3 Antithyroid Medications for Hyperthyroidism Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Antithyroid Medications for Hyperthyroidism and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Antithyroid Medications for Hyperthyroidism
  • 13.3 Antithyroid Medications for Hyperthyroidism Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Antithyroid Medications for Hyperthyroidism Typical Distributors
  • 14.3 Antithyroid Medications for Hyperthyroidism Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antithyroid Medications for Hyperthyroidism market size was valued at US$ 561 million in 2025 and is forecast to a readjusted size of US$ 845 million by 2032 with a CAGR of 6.1% during review period.
    Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Antithyroid Medications for Hyperthyroidism market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Antithyroid Medications for Hyperthyroidism market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Antithyroid Medications for Hyperthyroidism market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Antithyroid Medications for Hyperthyroidism market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Antithyroid Medications for Hyperthyroidism market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Antithyroid Medications for Hyperthyroidism
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Antithyroid Medications for Hyperthyroidism market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Herbrand PharmaChemicals, Future Health Pharma, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical, Zibo Wankang Pharmaceutical Chemical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Antithyroid Medications for Hyperthyroidism market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Methimazole
    Propylthiouracil
    Other
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Merck
    Herbrand PharmaChemicals
    Future Health Pharma
    Shanghai Zhaohui Pharmaceutical
    Beijing Yanjing Pharmaceutical
    Jinghua Pharmaceutical Group
    Guangzhou Kanghe Pharmaceutical
    Zigong Honghe Pharmaceutical
    Guangdong Huanan Pharmaceutical
    Zibo Wankang Pharmaceutical Chemical
    Qilu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Antithyroid Medications for Hyperthyroidism product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Antithyroid Medications for Hyperthyroidism, with price, sales quantity, revenue, and global market share of Antithyroid Medications for Hyperthyroidism from 2021 to 2026.
    Chapter 3, the Antithyroid Medications for Hyperthyroidism competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Antithyroid Medications for Hyperthyroidism breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Antithyroid Medications for Hyperthyroidism market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Antithyroid Medications for Hyperthyroidism.
    Chapter 14 and 15, to describe Antithyroid Medications for Hyperthyroidism sales channel, distributors, customers, research findings and conclusion.

    Buy now